Clinical trial
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center…
NCT00284050 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00284050 |
|---|---|
| Title | Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement |
| Official title | A Randomized, Double-masked, Multi-center, Phase II Study Assessing the Safety and Efficacy of Two Concentrations of Ranibizumab (Intravitreal Injections) Compared With Non-treatment Control for the Treatment of Diabetic Macular Edema With Center Involvement |
| Acronym | RESOLVE |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Ranibizumab 0.3 mg, Ranibizumab 0.5 mg, Sham injection |
| Enrollment | 151 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jan 31, 2006 |
| Last update posted | Feb 24, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: